The New York State Emerging Infections Program

Active Bacterial Core Surveillance (ABCs)

Publications

• Schrag SJ, Hadler J, Arnold KE, et al. Risk factors for invasive perinatal Escherichia coli sepsis in the era of widespread intrapartum antibiotic use. Pediatrics 2006; 118:570-6. PubMed
• Greene CM, Kyaw MH, Ray SM, Schaffner W, Lynfield R, Barrett NL, Long C, Gershamn K, Pilishvili, Roberson A, Zell ER, Whitney CG, Bennett NM for the Active Bacterial Core Surveillance Program of the Emerging Infections Program Network. Preventability of Invasive Pneumococcal Disease and Assessment of Current Polysaccharide Vaccine Recommendations for Adults: United States, 2001-2003. Clinical Infectious Diseases, 2006; 43:141-50. PubMed
• Kyaw MH, Greene CM, Schaffner W, Ray SM, Shapiro M, Barrett NL, Gershman K, Craig AS, Roberson A, Zell ER, Schuchat A, Bennett NM, Whitney CG; Active Bacterial Core Surveillance Program of the Emerging Infections Program Network. Adults with invasive pneumococcal disease: missed opportunities for vaccination. Am J Prev Med. 2006; 31:286-92. PubMed
• Kyaw MH, Lynfield R, Schaffner W, Craig AS, Halder J, Reingold A, Thomas AR, Harrison LH, Bennett NM, Farley MM, Facklam RR, Jorgensen JH, Besser J, Zell ER, Schuchat A, Whitney CG; Active Baterial Core Surveillance Program of the Emerging Infections Program Network. Effect of Introduction of the Pneumococcal Conjugate Vaccine on Drug-Resistant Streptococcus pneumoniae. N Eng J Med 2006; 354:1455-63. PubMed
• Poehling KA, Talbot TR, Griffin MR, Craig AS, Whitney CG, Zell E, Lexau CA, Thomas AR, Harrison LH, Reingold AL, Hadler JL, Farley MM, Anderson BJ, Schaffner W. Invasive Decline in Invasive Pneumococcal Disease Among Young Infants and Elimination of Racial Disparities in Disease Rates Following Introduction of the Pneumococcal Conjugate Vaccine. JAMA 2006; 295:1668-73. PubMed
• Whitney CG, Pilishvili T, Farley MM, Schaffner W, Craig AS, Lynfield R, Nyquist AC, Gershman KA, Vazquez M, Bennett NM, Reingold A, Thomas A, Glode MP, Zell ER, Jorgensen JH, Beall B, Schuchat A. Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study. Lancet 2006; 368:1495-502. PubMed
• Whitney CG, Farley MM, Hadler J, et al. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. New Engl J Med 2003; 348(18):1737-1746. PubMed
• Flannery B, Schrag S, Bennett NM, et al. Active Bacterial Core Surveillance/Emerging Infections Program Network. Impact of childhood vaccination on racial disparities in invasive Streptococcus pneumoniae infections. JAMA 2004; 291(18):2197-2203. PubMed
• Raghunathan PL, Bernhardt SA, Rosenstein NE. Opportunities for control of meningococcal disease in the United States. Ann Rev Med 2004; 55:333-353. PubMed
• King MD, Whitney CG, Parekh FM, and Farley MM. Recurrent Invasive Pneumococcal Disease: A Population-Based Assessment. Clin Infect Dis 2003; 37:1029-1036. PubMed
• Kupronis BA, Richards JC, Whitney CG, Team ABCS: Invasive pneumococcal disease among older adults residing in long-term care facilities and in the community. J Am Geriatr Soc 2003; 51(11):1520-1525. PubMed
• Sisk JE, Whang W, Butler JC, Sneller VP, Whitney CG. Cost-effectiveness of vaccination against invasive pneumococcal disease among people 50 through 64 years of age: role of co morbid conditions and race. Ann Intern Med 2003; 138(12): 960-968. PubMed
• Whitney CG, Farley MM, Hadler J, et al. Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States. N Engl J Med 2000; 343:1917-1924. PubMed
• Schuchat A, Robinson KA, Wenger JD, et al. Bacterial meningitis in the United States in 1995. N Engl J Med 1997; 337:970-976. PubMed
• Raghunathan PL, Bernhardt SA, Rosenstein NE. Opportunities for control of meningococcal disease in the United States. Ann Rev Med 2004; 55:333-353. PubMed
• Factor SH, Levine OS, Schwartz B, et al. Invasive group A streptococcal disease: risk factors for adults. Emerg Infect Dis 2003; 9(8): 970-977. PubMed
• Robinson KA, Rothrock G, Phan Q, et al. Risk for severe group A streptococcal disease among patients' household contacts. Emerg Infect Dis 2003; 9(4):443-447. PubMed
• Farley MM, Harvey RC, Stull T, et al. A population-based assessment of invasive disease due to group B streptococcus in nonpregnant adults. N Engl J Med 1993; 328:1807-1811. PubMed
• Schrag SJ, Zell ER, Lynfield R, et al. A population-based comparison of strategies to prevent early onset group Bstreptococcal disease in neonates. New Engl J Med 2002; 347:233-239. PubMed
• Ohuabunwo C, Bath S, Bisgard K, et al. Progress Toward Elimination of Haemophilus influenzae Type b Invasive Disease Among Infants and Children, United States, 1998--2000. MMWR Morb Mortal Wkly Rep 2002; 51(11); 234-237. PubMed
• Adams WG, Deaver KA, Cochi SL, et al. Decline of childhood Haemophilus influenzae Type b (Hib) disease in the Hib vaccine era. JAMA 1993; 269:221-226. PubMed
• Harrison LH, Pass MA, Mendelsohn AB, et al. Invasive menigococcal disease in adolescents and young adults. JAMA 2001; 286:694-699. PubMed